Muc M, Todo-Bom A, Mota-Pinto A, Vale-Pereira S, Loureiro C
Department of Life Sciences, Faculty of Science and Technology, University of Coimbra, Coimbra, Portugal.
Immunoallergology Department, Coimbra University Hospital, Coimbra, Portugal; Global Allergy and Asthma European Network, GA2LEN, Portugal.
Allergol Immunopathol (Madr). 2014 Sep-Oct;42(5):415-21. doi: 10.1016/j.aller.2013.03.004. Epub 2013 May 4.
Excess body mass increases the risk of development of asthmatic symptoms and their severity and decreases the treatment effectiveness. One of the hypotheses explaining the link between the two diseases concerns the adipokines, hormones produced by adipose tissue with a proinflammatory character. The aim of this study was to compare the levels of the adipokines (leptin and resistin) between overweight asthmatic patients, asthmatic patients with normal weight and overweight patients without asthma.
80 peripheral blood samples were collected from patients and blood serum extracted. Three groups were selected: overweight asthmatic patients (BMI≥25), overweight patients without asthma and asthmatic patients with normal weight (BMI<25). Waist circumference of the patients was measured (cut-off points were 80cm for women and over 94cm for men) and a skin prick test performed. Comparison of adipokine concentration between the 3 groups was made and association between these concentrations and the measurements was performed.
Although the concentrations of both adipokines were slightly higher for overweight asthmatic patients compared to overweight healthy patients, these differences were not significant. A significant association was found between leptin concentration and both BMI (p<0.01) and waist circumference (p<0.01). A difference for this cytokine was also found between asthmatic and non-asthmatic female patients (p<0.05).
As expected overweight patients with BMI≥25 and patients with increased waist circumference showed higher leptin levels. We suggest that the studied cytokines, with a stronger indication for leptin, can elicit asthmatic inflammation in obese phenotype of asthma that affects more frequently women.
体重超标会增加哮喘症状发生及加重的风险,并降低治疗效果。解释这两种疾病之间关联的一种假说涉及脂肪因子,即由脂肪组织产生的具有促炎特性的激素。本研究的目的是比较超重哮喘患者、体重正常的哮喘患者和非哮喘超重患者的脂肪因子(瘦素和抵抗素)水平。
收集80例患者的外周血样本并提取血清。选取三组:超重哮喘患者(BMI≥25)、非哮喘超重患者和体重正常的哮喘患者(BMI<25)。测量患者的腰围(女性的截断点为80cm,男性为94cm以上)并进行皮肤点刺试验。比较三组之间的脂肪因子浓度,并分析这些浓度与各项测量指标之间的关联。
尽管超重哮喘患者的两种脂肪因子浓度均略高于超重健康患者,但这些差异并不显著。发现瘦素浓度与BMI(p<0.01)和腰围(p<0.01)均存在显著关联。在哮喘女性患者和非哮喘女性患者之间也发现了这种细胞因子的差异(p<0.05)。
正如预期的那样,BMI≥25的超重患者和腰围增加的患者瘦素水平较高。我们认为,所研究的细胞因子,尤其是瘦素,在肥胖型哮喘(更常见于女性)中可能引发哮喘炎症。